药品战略进入延迟的成本估算:以安必恩CR为例

IF 1.3 4区管理学 Q3 BUSINESS

Qme-Quantitative Marketing and Economics Pub Date : 2016-08-25 DOI:10.1007/s11129-016-9170-9

Bradley T. Shapiro

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Estimating the cost of strategic entry delay in pharmaceuticals: The case of Ambien CR

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Qme-Quantitative Marketing and Economics Multiple-

CiteScore

2.30

自引率

10.50%

发文量

期刊介绍： Quantitative Marketing and Economics (QME) publishes research in the intersection of Marketing, Economics and Statistics. Our focus is on important applied problems of relevance to marketing using a quantitative approach. We define marketing broadly as the study of the interface between firms, competitors and consumers. This includes but is not limited to consumer preferences, consumer demand and decision-making, strategic interaction of firms, pricing, promotion, targeting, product design/positioning, and channel issues. We embrace a wide variety of research methods including applied economic theory, econometrics and statistical methods. Empirical research using primary, secondary or experimental data is also encouraged. Officially cited as: Quant Mark Econ